BAM
ARKG icon

Bruderman Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bruderman Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-160
Closed -$5K – 143
2019
Q1 		$5K Buy
160
+2
+1% +$59 ﹤0.01% 480
2018
Q4 		$4K Buy
+158
New +$4.45K ﹤0.01% 501

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Bruderman Asset Management's ARKG Position: Q2 2019 in Review

Bruderman Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2019, closing a stake of 160 shares — an estimated $5K sold.

Bruderman Asset Management first reported a position in ARKG in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 72 funds tracked by Wall St. Rank hold ARKG as of Q2 2019.

  • Bruderman Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2019 after selling out during the quarter.
  • Bruderman Asset Management sold 160 ARK Genomic Revolution ETF shares in Q2 2019, an estimated $5K.
  • Bruderman Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2018 and held it in 2 quarters.
  • Bruderman Asset Management's ARK Genomic Revolution ETF position peaked at $5K in Q1 2019.
  • 72 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.